尼古丁电子烟用于戒烟:临床药理学的视角
Victoria Ameral1,2, Mehmet Sofuoglu3,4, Megan M Kelly1,2
1VISN 1 Mental Illness Research, Education, and Clinical Center (MIRECC), VA Bedford Healthcare System, Bedford, MA, USA.
Expert review of clinical pharmacology
|March 6, 2025
概括
电子烟在戒烟方面表现有前途,相当于尼古丁替代疗法. 需要进一步的研究来证实它们在不同人群中的有效性,并监测临床指导方针的长期影响.
科学领域:
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
背景情况:
- 戒烟显著改善健康状况和预期寿命.
- 尽管有很高的戒烟意图,但很少有吸烟者计划立即戒烟.
- 电子烟正在成为戒烟的潜在工具.
研究的目的:
- 审查电子烟用于戒烟和减少危害的证据.
- 讨论电子烟的药理学和特征.
- 检查电子烟使用的高风险人群和弱势群体.
主要方法:
- 关于戒烟治疗的文献综述.
- 电子烟特征和药理学的分析.
- 检查支持电子烟戒烟的证据.
主要成果:
- 电子烟的疗效与尼古丁替代疗法的疗效相当.
- 证据支持电子烟作为拒绝治疗的吸烟者减少危害的选择.
- 具体的产品效应和长期结果需要进一步调查.
结论:
- 电子烟为戒烟提供了一个有希望的替代品.
- 进一步的研究对于特定人群和长期安全至关重要.
- 开发基于证据的临床指南是必要的.
更多相关视频
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
11.4K
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
25.3K
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Stimulants
156
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
156
CNS Depressants: Alcohol and Nicotine
166
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
166
Drug Dependence
965
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
965
Cholinergic Receptors: Nicotinic
2.1K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.1K
Drugs Acting on Autonomic Ganglia: Blockers
941
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
941
